• Join Newsletter
  • Login
  • Contact Us
  • Search
Prism RA
  • Get PrismRA
  • The PrismRA Result
  • For Physicians
  • Affordability
  • Lab & Sample Collection
Select Page

Thank You

Learn More About PrismRA

Interested in how PrismRA helps guide therapy decisions? Please contact the Scipher Medicine Client Services team.

Email IconSupport@Scipher.com

Phone Icon855-724-7437

Contact Us

Learn more about Scipher Medicine’s mission

Join Newsletter
PrismRA Molecular Signature Test

PrismRA is a molecular signature response classifier (MSRC) that uses gene expression features, clinical features and anti-cyclic citrullinated protein (anti-CCP) antibody to detect a signature of non-response to tumor necrosis factor-α inhibitors (TNFi) for patients with rheumatoid arthritis. PrismRA predicts the patient’s likelihood of inadequately responding to all TNFi therapies. Response is defined as achieving ACR50 at 6 months. The PrismRA result is reported on a continuous 1 to 25 scale. The higher the score, the more likely the patient will have an inadequate response to TNFi therapies; the lower the score, the less likely the patient will have an inadequate response to TNFi therapies. However, a low score does not ensure a positive response to TNFi therapies.

PrismRA for Patients

  • How PrismRA Helps You
  • Get PrismRA
  • The PrismRA Result
  • Find a Provider
  • Affordability
  • Join the Newsletter
  • Billing FAQs

For Physicians

  • The PrismRA Solution
  • PrismRA Development
  • The PrismRA Result Report
  • Ordering PrismRA
  • Publications & Tech Specs

Resources

  • Patient Brochure
  • Folleto Para Pacientes
  • Billing Brochure
  • Folleto Para Facturación
  • Financial Assistance
  • Patient Billing Portal
  • How to Talk to Your Doctor
  • Global Healthy Living Foundation

Scipher Medicine

  • Contact Us
  • PrismRA Lab Certifications
  • Scipher Lab Service Guide
  • Notice of Privacy Practices
  • Privacy Policy
  • Terms of Use
  • Cookies Acknowledgement
  • Patient Opt-Out Information
  • Right to Receive a Good Faith Estimate
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

2023 Scipher Medicine Corporation. All rights reserved. Scipher Medicine, PrismRA, and their logos are registered trademarks in the United States and other jurisdiction. RA-SA0004-003-230206